Guardant Health (GH) EBITDA Margin Growth (1y) (2018 - 2026)
Guardant Health (GH) EBITDA Margin Growth (1y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 50.00 |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 519.00 |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 136.00 |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 376.00 |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -101.00 |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 235.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 93.00 |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 352.00 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -78.00 |
| 10 | Guardant Health | 21.59 Bn | 20.53 Bn | 219.03 Mn | 731.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 731.00 |
| Mar 31, 2026 | 1,435.00 |
| Dec 31, 2025 | 1,947.00 |
| Sep 30, 2025 | 2,395.00 |
| Jun 30, 2025 | 1,092.00 |
| Mar 31, 2025 | 459.00 |
| Dec 31, 2024 | 6,497.00 |
| Sep 30, 2024 | 1,811.00 |
| Jun 30, 2024 | 3,044.00 |
| Mar 31, 2024 | 4,499.00 |
| Dec 31, 2023 | -1,223.00 |
| Sep 30, 2023 | 4,378.00 |
| Jun 30, 2023 | 3,219.00 |
| Mar 31, 2023 | 2,420.00 |
| Dec 31, 2022 | -2,431.00 |
| Sep 30, 2022 | -997.00 |
| Jun 30, 2022 | -1,339.00 |
| Mar 31, 2022 | 877.00 |
| Dec 31, 2021 | 2,557.00 |
| Sep 30, 2021 | -1,362.00 |